Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lapaquistat acetate is a squalene synthase inhibitor. It also blocks the conversion of farnesyl diphosphate (FPP) to squalene. Lapaquistat acetate is used to Mevalonate Kinase Deficiency (MKD), it is effective at lowering low-density lipoprotein cholesterol, but it might cause liver damage.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $3,819 | 10-14 weeks | |
50 mg | $5,328 | 10-14 weeks | |
100 mg | $6,929 | 10-14 weeks |
Description | Lapaquistat acetate is a squalene synthase inhibitor. It also blocks the conversion of farnesyl diphosphate (FPP) to squalene. Lapaquistat acetate is used to Mevalonate Kinase Deficiency (MKD), it is effective at lowering low-density lipoprotein cholester |
Alias | TAK-475 |
Molecular Weight | 645.14 |
Formula | C33H41ClN2O9 |
Cas No. | 189060-13-7 |
Relative Density. | 1.246 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 46 mg/mL (71.30 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.